£79K Secured for Human-Centric Digital Therapeutic Platform
Funds Secured
Learning with Experts (LWE) and Polyatrics Limited have secured £79,822 from Innovate UK to develop a groundbreaking digital therapeutic platform, Wellness Interactive Support Hub (W:ISH), focused on social prescribing and the management of long-term health conditions.
Introduction to W:ISH
W:ISH is designed to connect NHS patients with local services, healthy activities, and support groups through social prescribing. The collaboration between Learning with Experts and Polyatrics aims to integrate personalised healthcare education with digital tools to prevent long-term conditions like diabetes and cardiovascular diseases.
Goal
The project will use human-centred design principles to improve the usability and effectiveness of W:ISH transforming the platform into a fully interactive, social online learning environment leveraging motivational tools to drive long-term engagement and improve patient outcomes.
Why They Chose GrantUp
Learning with Experts turned to Grant Up for their proven expertise in securing healthcare grants and their impressive track record in navigating the intricate landscape of grant applications. Grant Up's ability to understand and articulate the transformative potential of the project was instrumental in the funding process.
Challenge
The UK’s ageing population is increasingly affected by lifestyle-related diseases, creating enormous demand for scalable health management solutions. Existing social prescribing platforms, while effective in linking patients to services, suffer from low engagement and high dropout rates (80%+).
Solution
The enhanced W:ISH platform will combine NHS interoperability with motivational and educational features, providing users with tailored content, group-learning options, and tools to better manage their health.
Opportunity
With the potential to impact millions of people who are at risk of long-term health conditions, W:ISH represents a significant opportunity for both the healthcare system and commercial stakeholders.
Results
A commercialised platform with wide applicability across the NHS and international markets.